Elastography test: What it measures, types, and how to read results

Key Takeaways

An elastography test measures how stiff tissues are, with stiffer tissue indicating fibrosis, scarring, or disease

Four main types exist: strain elastography, shear wave elastography, transient elastography (FibroScan), and MRI elastography (MRE)

Results are reported in kilopascals (kPa), with values above 7-9 kPa often indicating significant fibrosis, depending on etiology and guideline

Pabau’s automated recall workflows and digital forms help practices schedule, document, and follow up on repeat elastography monitoring

Most liver conditions progress silently. By the time symptoms appear, fibrosis is already advanced. The elastography test gives clinicians a way to catch that progression early, without a needle, without sedation, and without the sampling errors that make traditional biopsies unreliable.

The World Health Organization estimates that 304 million people are living with chronic hepatitis B or C, a leading driver of the liver fibrosis that elastography is used to detect. Non-invasive monitoring tools like this one have become the standard of care, and hepatologists, gastroenterologists, and specialist radiologists now use elastography routinely across outpatient settings.

This guide covers what an elastography test measures, how each type works, how to interpret the results, and how practices can build it into their diagnostic workflow effectively.

What is an elastography test?

An elastography test is a non-invasive imaging procedure that measures the stiffness of soft tissue. It works on a simple physical principle: diseased tissue is stiffer than healthy tissue. By quantifying that stiffness, clinicians can assess the degree of fibrosis, inflammation, or structural change without surgical intervention.

The liver is the primary focus, but elastography can also evaluate thyroid nodules, breast lesions, and musculoskeletal structures. For chronic liver conditions, it has largely replaced biopsy as the first-line assessment tool, which simplifies follow-up monitoring scheduling.

The Cleveland Clinic describes elastography as a test that uses “painless, low-frequency vibrations to check the elasticity of your body’s organs,” noting that stiff tissue “may signal disease, especially in the liver.” As the Clinic explains, “the most common reason for elastography is to check your liver for fibrosis.” It carries no ionizing radiation and requires no recovery time.

What does an elastography test measure?

The test measures tissue elasticity, specifically how much a tissue resists deformation when a mechanical force is applied. Results are typically reported in kilopascals (kPa), a unit of pressure that reflects stiffness.

Healthy liver tissue is soft and elastic. As fibrosis develops, collagen deposits replace functioning liver cells and the tissue stiffens. The elastography test captures that change numerically as a liver stiffness measurement, letting clinicians track disease progression or regression over time.

• kPa values: the standard unit for liver stiffness measurement across most elastography modalities
• Fibrosis staging (Metavir F0-F4): kPa values map to fibrosis grades, helping clinicians assess severity
• Steatosis measurement: some devices (notably FibroScan) also quantify fat content via a Controlled Attenuation Parameter (CAP) score
• Elastogram: in MRI-based elastography, a color-coded stiffness map of the entire organ is generated

Inflammation can also elevate stiffness readings temporarily, which is why results should always be interpreted alongside clinical context rather than in isolation. Tracking measurements over serial visits using measurements tracking software lets hepatology teams spot genuine progression versus transient changes.

How does an elastography test work?

The physics differ slightly by modality, but the core mechanism is consistent. A mechanical force (vibration, sound pulse, or magnetic gradient) is introduced into the tissue. The device measures how quickly the resulting shear waves propagate through it. Stiffer tissue transmits waves faster.

In ultrasound-based systems, the transducer both generates the acoustic push and measures wave speed. In MRI elastography, a pneumatic driver outside the bore produces low-frequency vibrations that travel through the patient’s body while the MRI captures the wave patterns.

The output is a quantitative stiffness value or, in the case of MRE, a full spatial map. Neither approach involves ionizing radiation, and both are well-tolerated by most patients. This is why the RSNA and ACR’s RadiologyInfo.org describes elastography as having “no known harmful effects.”

Types of elastography test

Four main modalities are in clinical use, and they fall into two families: ultrasound elastography (strain, shear wave, and transient or FibroScan) and MRI elastography. Each differs in equipment, technique, and the clinical scenarios where it performs best.

Transient elastography (FibroScan)

FibroScan is the most widely deployed standalone elastography device globally. It performs vibration-controlled transient elastography, sometimes written as a VCTE test. The probe emits a controlled vibration pulse and measures the resulting shear wave speed through liver tissue, reporting stiffness in kPa. It also captures the Controlled Attenuation Parameter (CAP) to quantify hepatic steatosis.

The procedure takes roughly 10-15 minutes and requires no sedation. Patients typically fast for 2-3 hours beforehand, as recent food intake can affect stiffness readings. For patients with elevated BMI, an XL probe is often required to achieve adequate signal depth. Results are available immediately after the scan.

Shear wave elastography

Shear wave elastography (SWE) is integrated into modern diagnostic ultrasound platforms from manufacturers including Siemens Healthineers, GE HealthCare, Philips, and Canon Medical. It uses Acoustic Radiation Force Impulse (ARFI) technology to generate a localized push pulse and measures the resulting shear wave velocity.

Because elastography ultrasound runs on the same machine as a standard abdominal ultrasound, SWE is highly practical for hepatology departments. Point SWE gives a single-site kPa value, while 2D SWE generates a color-coded stiffness map of a region. Both provide quantitative outputs suitable for serial monitoring in patient care management workflows for chronic liver disease.

MRI elastography (MRE)

Magnetic resonance elastography combines standard MRI acquisition with low-frequency mechanical vibrations delivered via a passive driver placed on the abdomen. The MRI captures wave propagation patterns across the entire liver and produces an elastogram: a color-coded stiffness map showing spatial variation in tissue stiffness.

MRE is considered the most accurate non-invasive method for advanced fibrosis staging, performing well even in patients where obesity limits ultrasound quality. The trade-off is time (30-60 minutes total scan time) and cost. Standard MRI contraindications apply: patients with certain metal implants or severe claustrophobia may not be suitable candidates.

What conditions can an elastography test detect?

Liver fibrosis staging is the dominant clinical application. Clinicians use the elastography test to monitor patients with chronic hepatitis B, chronic hepatitis C, non-alcoholic fatty liver disease (NAFLD/MASLD), alcohol-related liver disease, and autoimmune hepatitis.

Beyond the liver, elastography has established uses in characterizing thyroid nodules (distinguishing benign from suspicious lesions), evaluating breast masses, and assessing musculoskeletal tissue integrity. Functional medicine practices running metabolic health assessments increasingly include liver stiffness monitoring as part of comprehensive metabolic panels.

• Liver fibrosis: staging F0-F4 in hepatitis B, hepatitis C, NAFLD, and alcoholic liver disease
• Cirrhosis detection: identifying advanced fibrosis (F3-F4) without biopsy
• Treatment response: monitoring whether antiviral therapy or lifestyle changes are reducing liver stiffness
• Fatty liver disease: FibroScan’s CAP score quantifies hepatic fat content alongside fibrosis
• Non-liver applications: thyroid nodule characterization, breast lesion evaluation (strain elastography), musculoskeletal assessment

Elastography test vs liver biopsy: Key differences

The liver biopsy was the gold standard for fibrosis staging for decades. Elastography has not eliminated biopsy entirely, but clinical practice guidelines from EASL now position non-invasive testing, including elastography, as the preferred first-line approach for most patients with chronic liver disease.

Biopsy retains a role when elastography results are borderline, when a concurrent condition (autoimmune hepatitis, for example) needs histological confirmation, or when the clinical picture does not match the stiffness reading. Think of elastography as the filter that significantly reduces how many patients need to proceed to biopsy, not as a complete replacement in every scenario.

How to prepare for an elastography test

Preparation varies by modality, but a few rules apply broadly. Sending automated pre-appointment instructions ensures patients arrive prepared regardless of which type of elastography they are having.

• FibroScan / ultrasound SWE: fast for 2-3 hours before the test, wear comfortable and loose clothing, and avoid strenuous exercise on the day
• MRI elastography: fast as required for the MRI component, remove all metal objects, and inform the radiographer of any implants, pacemakers, or claustrophobia before booking
• Both modalities: no special medications to stop, no anesthetic needed, and most patients can drive themselves and return to normal activities immediately after

Patients with ascites (fluid in the abdominal cavity) may obtain unreliable FibroScan results. In those cases, clinicians typically opt for MRE or defer the elastography test until the ascites is managed. This is worth flagging during the booking triage process so patients are not called in for a test that will not yield usable data.

What to expect during and after the procedure

For a FibroScan or ultrasound SWE, the patient lies on a couch with their right arm raised. The operator applies gel to the skin and positions the probe over the right lobe of the liver, typically between the ribs.

The device fires a series of vibration pulses, and patients feel a very mild tapping sensation. Ten valid measurements are taken, and the median value is reported. The whole appointment, including positioning, takes 10-15 minutes.

MRE takes longer: 30-60 minutes total, including standard MRI sequences. The patient lies in the scanner bore with a passive driver (a pad) placed against their abdomen. They may be asked to hold their breath briefly at intervals. Claustrophobic patients may find this more challenging than the ultrasound-based alternatives.

After either procedure, there is no recovery period. Patients can eat, drive, and resume normal activities immediately. Results from FibroScan are available straight away, while MRE results need radiologist interpretation and are usually ready within a few days.

A patient portal for results communication lets the specialist share a summary as soon as it’s ready, so patients get their results securely without an extra phone call or follow-up appointment.

How to interpret elastography results

Liver stiffness values are reported in kPa, and they correspond to fibrosis grades using the Metavir scoring system (F0 = no fibrosis, F4 = cirrhosis).

The thresholds below are based on EASL clinical practice guidelines for non-invasive liver disease assessment. They apply specifically to patients with chronic hepatitis C. Thresholds shift for NAFLD and cholestatic liver disease, so the treating specialist must apply the correct reference range.

For NAFLD patients, significant fibrosis thresholds are generally higher (F2 around 8-10 kPa), because fatty infiltration itself can elevate stiffness independent of fibrosis. Etiology-specific reference tables from AASLD and EASL should be consulted for each patient population. An isolated kPa number without clinical context is not a diagnosis.

Limitations and factors that affect accuracy

No test is perfect. Clinicians relying solely on the elastography test number without considering confounders risk acting on misleading data. The key factors that can falsely elevate stiffness readings include:

• Acute hepatitis or inflammation: active inflammation stiffens tissue temporarily, independent of fibrosis, and can push readings into the F3-F4 range even in early-stage disease
• Recent food intake: portal blood flow increases after eating, raising liver stiffness for 1-2 hours post-meal
• Elevated BMI: subcutaneous fat reduces ultrasound signal quality, so an XL probe is often required for reliable FibroScan readings in patients with BMI above 30
• Ascites: fluid in the peritoneal cavity interferes with shear wave propagation and makes results unreliable
• Operator technique: probe placement, patient breathing, and acquisition quality all influence result reliability

According to MedlinePlus (National Library of Medicine), accuracy can be affected by liver inflammation, tumors, obesity, and abnormal fluid buildup in the abdomen, so a specialist should interpret findings in the full clinical context. For borderline readings (F1-F2 boundary), combining the elastography test result with blood-based biomarkers (FIB-4 index, APRI score) is common practice per AASLD guidance.

How practices can integrate an elastography test into their diagnostic workflow

Clinical references explain what elastography measures. They say far less about the logistics of running a high-quality elastography monitoring program at scale.

Chronic liver disease patients typically need elastography every 6-12 months to track progression. That creates a predictable, repeatable scheduling need. Without a structured recall system, patients fall through the cracks, results go undocumented, and clinicians lose the longitudinal data that makes elastography clinically meaningful. Patient recall software that links each test to a scheduled follow-up changes that dynamic.

• Recall scheduling: set a 6 or 12-month automated recall after each elastography appointment so follow-up never depends on a manual chase
• Pre-appointment forms: use digital forms to capture updated medication history and BMI before each visit, flagging patients who may need an XL probe or MRE referral
• Results documentation: record kPa values against each visit in the patient record so the trend is visible at a glance, not buried across different consultation notes
• Follow-up automation: trigger post-appointment instructions and referral letters automatically based on the fibrosis stage documented in the visit notes

Practice management software like Pabau handles the scheduling side of this. Its automated recall workflows mean that once a clinician completes an elastography visit and documents the result, the system triggers the next monitoring appointment invitation automatically, with pre-set fasting instructions included in the confirmation. That removes the administrative burden from the clinical team while keeping the monitoring program consistent.

For multi-site hepatology services, patient engagement between monitoring visits matters too. Educational resources, lifestyle guidance, and check-ins via the patient portal can be automated to support behavior change between elastography appointments.

Secure patient data handling for diagnostic results is a compliance baseline any practice running structured diagnostic monitoring must address. Want to see how Pabau structures diagnostic follow-up pathways? Book a demo to walk through the workflow.

The bottom line on the elastography test

The elastography test has changed liver disease management by making serial, non-invasive fibrosis monitoring practical for outpatient settings. Choosing the right modality, preparing patients correctly, and interpreting kPa values against the right etiology-specific reference tables are the three areas where practice teams most commonly encounter avoidable errors.

Operationally, this test only delivers value if monitoring programs run consistently. Pabau’s record and recall tools give specialist practices the infrastructure to run elastography-based monitoring programs without manual follow-up burden. If your hepatology or gastroenterology service is expanding diagnostic capacity, see medical practice scheduling software options that integrate with diagnostic workflows.

Continue your research

Need to structure patient records for chronic disease monitoring? Patient care management workflows covers how specialist practices organize longitudinal data across repeat diagnostic visits.

Looking for intake form best practices before diagnostic appointments? Medical forms at your healthcare practice outlines how digital pre-visit forms reduce errors and save clinical time.

Need to document the clinical reasoning behind an ambiguous result? Medical decision making (MDM) breaks down the documentation levels that support that call.

Curious how other diagnostic systems structure severity grading? Danis-Weber classification shows how a similar staged grading system works for ankle fractures.

Documenting findings across other structured clinical assessments? Mental state examination covers documentation for a different but equally structured diagnostic workflow.

Frequently asked questions